SAGE-217 reduces depressive symptoms in patients with major depression within 2 weeks - 2 Minute Medicine

Submitted by Anonymous (not verified) on Fri, 09/20/2019 - 16:53

SAGE-217 reduces depressive symptoms in patients with major depression within 2 weeks  2 Minute Medicine1. Patients with major depression randomized to receive SAGE-217, a positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors, experienced ...